Of all the biological markers under investigation, only the NfL blood concentrations at the baseline could discriminate patients with ALS from NNC using a receiver operating characteristic binary classification system (Supplementary Figure S3C, AUC: 0.9487, p < 0.0001). The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.